Over 50% of prescription drug spend is on 2% of patients with chronic illness.
It’s time for a new approach tailored to the unique needs of specialty patients.
Average client first year savings
We are setting the bar for effective specialty drug management providing sustainable cost control and true clinical care.
Discover how Archimedes is providing significant, ongoing savings for our clients that is unmatched in the industry.
Learn MoreDiscover how Archimedes is disrupting the outdated PBM model for managing specialty drugs.
Learn More
We make 100% of our revenue from fees paid by our clients, which means we serve the best interest of our clients and no one else – not the pharmaceutical manufacturers, not the pharmacies – no one.
Medical specialty drugs make up 40% of the specialty drug spend.
Archimedes offers unparalleled solutions to address the unique challenges of specialty drugs covered under the medical benefit.
Learn More
Update your browser to view this website correctly. Update my browser now
